Table 2.

Effect of concentration of aspirin, quercetin and PG9 capped and quercetin functionalized AuNPs on the % inhibition of hemolysis

Concentration (ppm)		% Inhibition
		Aspirin	Quercetin	AuNPs-PG9-QT
	200	− 24.70 ± 5.03	7.50 ± 7.64	48.60 ± 8.50
	400	− 17.02 ± 2.98	27.22 ± 6.22	56.33 ± 15.09
	600	− 4.68 ± 2.49	65.05 ± 6.36	59.08 ± 1.65
	800	− 27.60 ± 6.66	89.51 ± 5.49	52.86 ± 3.97
	1000	− 14.81 ± 3.4	93.27 ± 10.89	69.90 ± 3.77
	1200	− 13.58 ± 0.91	95.36 ± 6.53	73.35 ± 8.51
	1400	− 9.26 ± 0.74	97.62 ± 8.19	74.51 ± 21.16
	1600	6.18 ± 1.51	99.51 ± 6.55	87.46 ± 6.83
	1800	3.51 ± 1.3	93.97 ± 8.41	88.52 ± 8.67
	2000	3.48 ± 1.61	96.85 ± 6.67	91.26 ± 6.25
IC50		− 14.195 ± 2.15	94.315 ± 8.71	71.62 ± 6.14